A Maryland-specific peptide guide connecting seller and pharmacy claims to the state's official license route while keeping prescription, compounding, and laboratory research categories separate.
US research listing snapshotCompare 7 current BPC-157 listingsExact-size public listings kept separate from clinics and pharmacies.↓In Maryland, a local address, shipment promise, clinic page, or pharmacy name is only a starting claim. Maryland Board of Pharmacy provides a facility-focused verification search for board-regulated pharmacy records, while federal product and compounding records answer separate questions.
Use this checklist to verify the local product, seller, and supply records before comparing price or availability.
Use board of pharmacy facility verification to match the legal name, license type, address, and current status behind a pharmacy, professional, or facility claim involving Maryland.
A Maryland credential does not approve every product, ingredient, presentation, compounding basis, prescription route, or delivery claim. Check the applicable FDA record independently.
Keep prescription care, compounded preparations, telehealth services, and laboratory research listings in separate lanes. For market rows, compare the same nominal size, availability date, shipping basis, and evidence access.
Each answer is tied to the local records below so you can see what is confirmed, what remains unknown, and where to recheck it. Open the primary sources ↓
No blanket answer is supportable. Use board of pharmacy facility verification to match the legal name, license type, address, and current status behind a pharmacy, professional, or facility claim involving Maryland. In Maryland, begin with Board of Pharmacy facility verification from Maryland Board of Pharmacy; the product, seller, and supply route still need to resolve to the same current record.
No. In Maryland, the 78 us listings / 20 boards shown here are national laboratory-research catalog observations ordered by availability and public list price at a matched nominal size. They do not rank local pharmacies, clinics, prescription access, medical suitability, safety, or quality.
For Maryland, start with Board of Pharmacy facility verification from Maryland Board of Pharmacy, then open Locate a state-licensed online pharmacy from U.S. Food and Drug Administration. The records answer separate questions, so confirm each current entry instead of treating one match as proof of the seller, product, and route together.
Each answer preserves the compound’s research, clinical, or medicine identity and then points to the official Maryland verification route. A shared name or state license is not a blanket product, seller, legal, or availability finding.
KPV in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗BPC-157 in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗TB-500 in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗GHK-Cu in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Semax in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Melanotan II in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗MOTS-c in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Tesamorelin in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗AOD-9604 in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Ipamorelin in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Selank in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗PT-141 / Bremelanotide in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗CJC-1295 no DAC in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗CJC-1295 DAC in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Retatrutide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Mazdutide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Ecnoglutide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Enicepatide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Eloralintide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Cagrilintide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Petrelintide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗CagriSema in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗MariTide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Survodutide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗VK2735 in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Pemvidutide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Amycretin / Zenagamtide in Maryland refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Tirzepatide in Maryland begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Orforglipron / Foundayo in Maryland begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Semaglutide in Maryland begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗DSIP / Emideltide in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗IGF-1 LR3 in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Kisspeptin-10 / KP-10 in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Melanotan I in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗NAD+ in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Sermorelin in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Thymosin Alpha-1 in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗EGRIFTA WR in Maryland begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗Liraglutide in Maryland begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗SCENESSE in Maryland begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗VYLEESI in Maryland begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Official state recordBoard of Pharmacy facility verificationMaryland Board of Pharmacy ↗These listings are for laboratory research materials. They are not local clinics, pharmacies, or approved products for human use.
Rank rule. Price rank is availability-aware and stays fixed when you search or re-sort this view. Affiliate status never enters the calculation.
Compare two lowest in-stock rowsChecked July 28, 2026 at 4:47 PM UTC. Confirmed means the public source matched the published price and returned a reliable current availability signal. No row needs manual review. This does not verify vial contents or product quality.
Open source-check ledger| Price rank / supplier | 10 mg price | Price / mg | Public evidence | Shipping claim | Open listing |
|---|---|---|---|---|---|
01Pure Health PeptidesPrice and stock confirmed Jul 27In stock | $40.00Source confirmed | $4.00 | Public lot COA libraryAccess: Public link · Seller claim · Jul 27, 2026 | Free shipping over $175; lower-order rate at checkout | |
02Purgo LabsCurrent public batch reportIn stock | $44.99Source confirmed | $4.50 | Public batch reportsAccess: Public link · Seller claim · Jul 23, 2026 | Live UPS rate; free UPS 3 Day Select over $250 | |
03Pepta LabsFree US shipping claimedIn stock | $52.79Source confirmed | $5.28 | COA on requestAccess: On request · Seller claim · Jul 23, 2026 | Free US shipping claimed | |
04Prime PeptidesPublic report linkedIn stock | $60.00Source confirmed | $6.00 | Report displayedAccess: Public link · Seller claim · Jul 23, 2026 | $9.95 US; free over $150 | |
05Biotech PeptidesPublic size-specific documentsIn stock | $92.00Source confirmed | $9.20 | COA, LC, and MS imagesAccess: Public link · Seller claim · Jul 23, 2026 | Free USPS Priority over $200; lower-order rate not stated | |
06AminoCore ResearchPrice confirmed; stock not statedStatus not stated | $55.00Source confirmed | $5.50 | COA includedAccess: Included with order · Seller claim · Jul 23, 2026 | Free shipping claimed | |
07Core PeptidesPrice shown; stock label absentStatus not stated | $97.00Source confirmed | $9.70 | COA tab shownAccess: Public link · Seller claim · Jul 23, 2026 | Free over $200; lower-order rate at checkout |
Official sources are linked directly. Open them to confirm the current record; this page is a guide, not a substitute for the regulator.